Analyzing CryoPort (CYRX) and Its Rivals

CryoPort (NASDAQ:CYRX) is one of 109 public companies in the “Life Sciences Tools & Services” industry, but how does it weigh in compared to its peers? We will compare CryoPort to related businesses based on the strength of its risk, dividends, analyst recommendations, profitability, valuation, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for CryoPort and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CryoPort	0	2	8	0	2.80
CryoPort Competitors	945	3159	5471	176	2.50

CryoPort presently has a consensus price target of $19.33, suggesting a potential upside of 11.82%. As a group, “Life Sciences Tools & Services” companies have a potential downside of 4.28%. Given CryoPort’s stronger consensus rating and higher possible upside, equities research analysts clearly believe CryoPort is more favorable than its peers.

Valuation and Earnings

This table compares CryoPort and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
CryoPort	$176.18 million	$78.30 million	-19.21
CryoPort Competitors	$2.26 billion	$55.88 billion	-13.90

CryoPort’s peers have higher revenue and earnings than CryoPort. CryoPort is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

CryoPort has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, CryoPort’s peers have a beta of 1.14, indicating that their average share price is 14% more volatile than the S&P 500.

Institutional & Insider Ownership

92.9% of CryoPort shares are held by institutional investors. Comparatively, 53.7% of shares of all “Life Sciences Tools & Services” companies are held by institutional investors. 9.5% of CryoPort shares are held by insiders. Comparatively, 15.0% of shares of all “Life Sciences Tools & Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares CryoPort and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CryoPort	-20.05%	-7.20%	-4.30%
CryoPort Competitors	-540.70%	-166.44%	-13.58%

Summary

CryoPort beats its peers on 8 of the 13 factors compared.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.